De heer dr. R.J.M. (Raymond) Niesink

Functie:

Senior wetenschappelijk medewerker

Programma:

Drug Monitoring

Telefoon

+31 (0)30 - 2971(171)
Neem contact op

Secretariaat:

Projecten van deze medewerker

Als projectleider:

• THC-monitoring
• Bureau DIMS
• Onderzoek Tabakswet in relatie tot coffeeshops 2009

Publicaties van deze medewerker

Verschenen publicaties in tijdschriften:

• Adolescent brain maturation, the endogenous cannabinoid system and he neurobiology of cannabis-induced schizophrenia
• Farmacologische en toxicologische aspecten van gammahydroxyboterzuur (GHB)
• Cannabis en verslaving: feiten en misverstanden
• The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes
• Hallucinogene paddenstoelen
• Toxicology now and in the future. Toxicology at the Trimbos Institute: monitoring and risk assessment of illicit psychotropic drugs
• An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants
• mCPP: an undesired addition to the ecstasy market
• Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
• Qat: farmacologische en toxicologische aspecten
• The drug information and monitoring system (DIMS) in the Netherlands: implementation, results, and international comparison
• Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users
• Methylone and mCPP, two new drugs of abuse?
• Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB) : a review of the literature
• Koffie en energiedrankjes: farmacologie en toxicologie van cafeïne
• Instability of the ecstasy market and a new kid on the block: mephedrone
• Content of ecstasy in the Netherlands: 1993–2008
• Partydrugs. Als drugs geen feest meer zijn
• Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops
• Instability of the ecstasy market and a new kid on the block: mephedrone